This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2003 Jun 12;348(24):2375-6.

doi: 10.1056/NEJMp030049.

Hodgkin's disease--clinical trials and travails

Vincent T DeVita Jr¹

Affiliations

PMID: 12802021
DOI: 10.1056/NEJMp030049

Comment

Hodgkin's disease--clinical trials and travails

Vincent T DeVita Jr. N Engl J Med. 2003.

. 2003 Jun 12;348(24):2375-6.

doi: 10.1056/NEJMp030049.

Author

Vincent T DeVita Jr¹

Affiliation

¹ Yale Cancer Center, Yale University School of Medicine and Yale-New Haven Hospital, New Haven, Conn, USA.

PMID: 12802021
DOI: 10.1056/NEJMp030049

Erratum in

N Engl J Med. 2003 Jul 10;349(2):202

No abstract available

PubMed Disclaimer

Comment on

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dörken B, Müller-Hermelink HK, Dühmke E, Loeffler M; German Hodgkin's Lymphoma Study Group. Diehl V, et al. N Engl J Med. 2003 Jun 12;348(24):2386-95. doi: 10.1056/NEJMoa022473. N Engl J Med. 2003. PMID: 12802024 Clinical Trial.
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
Aleman BM, Raemaekers JM, Tirelli U, Bortolus R, van 't Veer MB, Lybeert ML, Keuning JJ, Carde P, Girinsky T, van der Maazen RW, Tomsic R, Vovk M, van Hoof A, Demeestere G, Lugtenburg PJ, Thomas J, Schroyens W, De Boeck K, Baars JW, Kluin-Nelemans JC, Carrie C, Aoudjhane M, Bron D, Eghbali H, Smit WG, Meerwaldt JH, Hagenbeek A, Pinna A, Henry-Amar M; European Organization for Research and Treatment of Cancer Lymphoma Group. Aleman BM, et al. N Engl J Med. 2003 Jun 12;348(24):2396-406. doi: 10.1056/NEJMoa022628. N Engl J Med. 2003. PMID: 12802025 Clinical Trial.

Similar articles

14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group. Sieber M, et al. J Clin Oncol. 2003 May 1;21(9):1734-9. doi: 10.1200/JCO.2003.06.028. J Clin Oncol. 2003. PMID: 12721249 Clinical Trial.
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dörken B, Müller-Hermelink HK, Dühmke E, Loeffler M; German Hodgkin's Lymphoma Study Group. Diehl V, et al. N Engl J Med. 2003 Jun 12;348(24):2386-95. doi: 10.1056/NEJMoa022473. N Engl J Med. 2003. PMID: 12802024 Clinical Trial.
Chemotherapy for Hodgkin's disease.
Ekert H. Ekert H. N Engl J Med. 2003 Sep 18;349(12):1186-7; author reply 1186-7. doi: 10.1056/NEJM200309183491217. N Engl J Med. 2003. PMID: 13679536 No abstract available.
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
Longo DL, DeVita VT Jr. Longo DL, et al. Important Adv Oncol. 1992:155-65. Important Adv Oncol. 1992. PMID: 1582671 Review. No abstract available.
The cure of Hodgkin's disease with drugs.
DeVita VT Jr, Hubbard SM, Moxley JH 3rd. DeVita VT Jr, et al. Adv Intern Med. 1983;28:277-302. Adv Intern Med. 1983. PMID: 6188346 Review. No abstract available.

See all similar articles

Cited by

Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphoma.
Song MK, Chung JS, Lee JJ, Jeong SY, Lee SM, Hong JS, Chong A, Moon JH, Kim JH, Lee SM, Kim SJ, Shin HJ. Song MK, et al. Cancer Sci. 2013 Dec;104(12):1656-61. doi: 10.1111/cas.12282. Epub 2013 Oct 23. Cancer Sci. 2013. PMID: 24033666 Free PMC article.
Hodgkin Lymphoma: Differences in Treatment Between Europe and the United States/North America: Evolving Trends in Protocol Therapy.
FitzGerald TJ, Bishop-Jodoin M. FitzGerald TJ, et al. Clin Med Insights Oncol. 2018 Jan 31;12:1179554918754885. doi: 10.1177/1179554918754885. eCollection 2018. Clin Med Insights Oncol. 2018. PMID: 29434481 Free PMC article. Review.
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
Skoetz N, Will A, Monsef I, Brillant C, Engert A, von Tresckow B. Skoetz N, et al. Cochrane Database Syst Rev. 2017 May 25;5(5):CD007941. doi: 10.1002/14651858.CD007941.pub3. Cochrane Database Syst Rev. 2017. PMID: 28541603 Free PMC article.
Does radiotherapy still have a place in Hodgkin lymphoma?
Yahalom J. Yahalom J. Curr Hematol Malig Rep. 2009 Jul;4(3):117-24. doi: 10.1007/s11899-009-0017-2. Curr Hematol Malig Rep. 2009. PMID: 20425424 Review.
Risk, characteristics, and prognosis of breast cancer after Hodgkin's lymphoma.
Veit-Rubin N, Rapiti E, Usel M, Benhamou S, Vinh-Hung V, Vlastos G, Bouchardy C. Veit-Rubin N, et al. Oncologist. 2012;17(6):783-91. doi: 10.1634/theoncologist.2011-0451. Epub 2012 May 15. Oncologist. 2012. PMID: 22588325 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information